To the best of our knowledge, this is the first report that has addressed serum levels of chemerin from breast cancer patients and healthy individuals, and evaluated its role for the diagnosis and prognosis of patient with breast cancer. The gene discussed is RARRES2; the disease is breast carcinoma.